Can highly regulated pharmaceutical companies use AI effectively? What are companies doing to leverage AI without compromising their CGMP-validated processes? Please join this practical, real-world conversation on moving AI in pharma beyond pilots and into meaningful results. Tech-Clarity’s Julie Fraser joins a panel discussion with Sam Laermans, Global AI Lead at NNIT, Senior IT Leader…
Proof-of-Concept
AI Progress in Improving Industry Productivity
Jim Brown is moderating an AMC Bridge Expert Panel discussion on AI progress in industry. Has AI delivered on the hype? Are manufacturing and AEC companies adopting AI-driven use cases that drive real business value? Have we moved beyond the proof-of-concept phase in AI adoption? The panel will discuss these questions and more to shed…

